Cytokine-induced oxidative stress in cardiac inflammation and heart failure-how the ubiquitin proteasome system targets this vicious cycle

Frontiers in Physiology

Volumn 4 MAR, Issue , 2013, Pages

  Voigt, Antje ^a,b   Rahnefeld, Anna ^a   Kloetzel, Peter M ^a   Krüger, Elke ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Cytokines; Inflammation; Oxidative stress; Proteasome; Protein quality control

Indexed keywords

CYTOKINE; FREE RADICAL; HEAT SHOCK PROTEIN 90; INTERLEUKIN 6; KELCH LIKE ECH ASSOCIATED PROTEIN 1; NITRIC OXIDE SYNTHASE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEASOME; PROTEIN KINASE B; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; CARDITIS; CELL STRESS; CYTOKINE PRODUCTION; ENDOPLASMIC RETICULUM STRESS; HEART FAILURE; HEART MUSCLE; HUMAN; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN METABOLISM; PROTEIN TARGETING; UBIQUITINATION; UPREGULATION;

EID: 84879492973     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2013.00042     Document Type: Article

References (50)

1. Aki, M., Shimbara, N., Takashina, M., Akiyama, K., Kagawa, S., Tamura, T., et al. (1994). Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J. Biochem. 115, 257-269.
2. Basler, M., Dajee, M., Moll, C., Groettrup, M., and Kirk, C. J. (2010). Prevention of experimental colitis by a selective inhibitor of the immunoproteasome. J. Immunol. 185, 634-641.
3. Burgoyne, J. R., Mongue-Din, H., Eaton, P., and Shah, A. M. (2012). Redox signaling in cardiac physiology and pathology. Circ. Res. 111, 1091-1106.
4. Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., et al. (2006). NADPH oxidases in cardiovascular health and disease. Antioxid. Redox Signal. 8, 691-728.
5. Chen, F., Pandey, D., Chadli, A., Catravas, J. D., Chen, T., and Fulton, D. J. (2011). Hsp90 regulates NADPH oxidase activity and is necessary for superoxide but not hydrogen peroxide production. Antioxid. Redox Signal. 14, 2107-2119.
6. Chen, F., Yu, Y., Qian, J., Wang, Y., Cheng, B., Dimitropoulou, C., et al. (2012). Opposing actions of heat shock protein 90 and 70 regulate nicotinamide adenine dinucleotide phosphate oxidase stability and reactive oxygen species production. Arterioscler. Thromb. Vasc. Biol. 32, 2989-2999.
7. Ciechanover, A. (1994). The ubiquitin-proteasome proteolytic pathway. Cell 79, 13-21.
8. Dantuma, N. P., and Lindsten, K. (2010). Stressing the ubiquitin-proteasome system. Cardiovasc. Res. 85, 263-271.
9. Ebstein, F., Lange, N., Urban, S., Seifert, U., Kruger, E., and Kloetzel, P. M. (2009). Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system. Int. J. Biochem. Cell Biol. 41, 1205-1215.
10. Esfandiarei, M., and McManus, B. M. (2008). Molecular biology and pathogenesis of viral myocarditis. Annu. Rev. Pathol. 3, 127-155.
11. Fernandez-Velasco, M., Prieto, P., Terron, V., Benito, G., Flores, J. M., Delgado, C., et al. (2012). NOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis. PLoS ONE 7:e45260. doi: 10.1371/journal.pone.0045260
12. Fornace, A. J., Alamo, I., Hollander, M. C., and Lamoreaux, E. (1989). Ubiquitin messenger-RNA is a major stress-induced transcript in mammalian-cells. Nucleic Acids Res. 17, 1215-1230.
13. Gomes, A. V., Zong, C., Edmondson, R. D., Li, X., Stefani, E., Zhang, J., et al. (2006). Mapping the murine cardiac 26S proteasome complexes. Circ. Res. 99, 362-371.
14. Groll, M., Bajorek, M., Kohler, A., Moroder, L., Rubin, D. M., Huber, R., et al. (2000). A gated channel into the proteasome core particle. Nat. Struct. Biol. 7, 1062-1067.
15. Grune, T., Reinheckel, T., and Davies, K. J. A. (1997). Degradation of oxidized proteins in mammalian cells. FASEB J. 11, 526-534.
16. Huber, E. M., Basler, M., Schwab, R., Heinemeyer, W., Kirk, C. J., Groettrup, M., et al. (2012). Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity. Cell 148, 727-738.
17. Kalim, K. W., Basler, M., Kirk, C. J., and Groettrup, M. (2012). Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation. J. Immunol. 189, 4182-4193.
18. Kawai, T., and Akira, S. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650.
19. Kettern, N., Rogon, C., Limmer, A., Schild, H., and Hohfeld, J. (2011). The Hsc/Hsp70 co-chaperone network controls antigen aggregation and presentation during maturation of professional antigen presenting cells. PLoS ONE 6:e16398. doi: 10.1371/journal.pone.0016398
20. Khaper, N., Bryan, S., Dhingra, S., Singal, R., Bajaj, A., Pathak, C. M., et al. (2010). Targeting the vicious inflammation-oxidative stress cycle for the management of heart failure. Antioxid. Redox Signal. 13, 1033-1049.
21. Koch, A., Steffen, J., and Kruger, E. (2011). TCF11 at the crossroads of oxidative stress and the ubiquitin proteasome system. Cell Cycle 10, 1200-1207.
22. Komander, D. (2009). The emerging complexity of protein ubiquitination. Biochem. Soc. Trans. 37, 937-953.
23. Kruger, E., and Kloetzel, P. M. (2012). Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme. Curr. Opin. Immunol. 24, 77-83.
24. Kwak, M. K., Wakabayashi, N., Greenlaw, J. L., Yamamoto, M., and Kensler, T. W. (2003). Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol. Cell. Biol. 23, 8786-8794.
25. Lelouard, H., Ferrand, V., Marguet, D., Bania, J., Camosseto, V., David, A., et al. (2004). Dendritic cell aggresome-like induced structures are dedicated areas for ubiquitination and storage of newly synthesized defective proteins. J. Cell Biol. 164, 667-675.
26. Li, J., Powell, S. R., and Wang, X. J. (2011). Enhancement of proteasome function by PA28 alpha overexpression protects against oxidative stress. FASEB J. 25, 883-893.
27. Liu, J. B., Chen, Q. H., Huang, W., Horak, K. M., Zheng, H. Q., Mestril, R., et al. (2006). Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts. FASEB J. 20, 362-364.
28. Liu, Y., Chen, G. Y., and Zheng, P. (2009). CD24-Siglec G/10 discriminates danger- from pathogen-associated molecular patterns. Trends Immunol. 30, 557-561.
29. Mann, D. L. (2011). The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ. Res. 108, 1133-1145.
30. Meiners, S., Ludwig, A., Stangl, V., and Stangl, K. (2008). Proteasome inhibitors: poison's and remedies. Med. Res. Rev. 28, 309-327.
31. Miller, Y. I., Choi, S. H., Wiesner, P., Fang, L., Harkewicz, R., Hartvigsen, K., et al. (2011). Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res. 108, 235-248.
32. Muchamuel, T., Basler, M., Aujay, M. A., Suzuki, E., Kalim, K. W., Lauer, C., et al. (2009). A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat. Med. 15, 781-787.
33. Opitz, E., Koch, A., Klingel, K., Schmidt, F., Prokop, S., Rahnefeld, A., et al. (2011). Impairment of immunoproteasome function by beta5i/LMP7 subunit deficiency results in severe enterovirus myocarditis. PLoS Pathog. 7:e1002233. doi: 10.1371/journal.ppat.1002233
34. Pickering, A. M., and Davies, K. J. (2012). Differential roles of proteasome and immunoproteasome regulators Pa28alphabeta, Pa28gamma and Pa200 in the degradation of oxidized proteins. Arch. Biochem. Biophys. 523, 181-190.
35. Powell, S. R., Herrmann, J., Lerman, A., Patterson, C., and Wang, X. (2012). The ubiquitin-proteasome system and cardiovascular disease. Prog. Mol. Biol. Transl. Sci. 109, 295-346.
36. Predmore, J. M., Wang, P., Davis, F., Bartolone, S., Westfall, M. V., Dyke, D. B., et al. (2010). Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation 121, 997-1004.
37. Rahnefeld, A., Ebstein, F., Albrecht, N., Opitz, E., Kuckelkorn, U., Stangl, K., et al. (2011). Antigen-presentation capacity of dendritic cells is impaired in ongoing enterovirus myocarditis. Eur. J. Immunol. 41, 2774-2781.
38. Schmidt, N., Gonzalez, E., Visekruna, A., Kuhl, A. A., Loddenkemper, C., Mollenkopf, H., et al. (2010). Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis. Gut 59, 896-906.
39. Seifert, U., Bialy, L. P., Ebstein, F., Bech-Otschir, D., Voigt, A., Schroter, F., et al. (2010). Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142, 613-624.
40. Sijts, A. J. A. M., Standera, S., Toes, R. E. M., Ruppert, T., Beekman, N. J. C. M., van Veelen, P. A., et al. (2000). MHC class I antigen processing of an Adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells. J. Immunol. 164, 4500-4506.
41. Steffen, J., Seeger, M., Koch, A., and Kruger, E. (2010). Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol. Cell 40, 147-158.
42. Strehl, B., Joeris, T., Rieger, M., Visekruna, A., Textoris-Taube, K., Kaufmann, S. H. E., et al. (2006). Immunoproteasomes are essential for clearance of Listeria monocytogenes in nonlymphoid tissues but not for induction of bacteria-specific CD8(+) T cells. J. Immunol. 177, 6238-6244.
43. Szalay, G., Meiners, S., Voigt, A., Lauber, J., Spieth, C., Speer, N., et al. (2006). Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes. Am. J. Pathol. 168, 1542-1552.
44. Szeto, J., Kaniuk, N. A., Canadien, V., Nisman, R., Mizushima, N., Yoshimori, T., et al. (2006). ALIS are stress-induced protein storage compartments for substrates of the proteasome and autophagy. Autophagy 2, 189-199.
45. Tian, Z. W., Zheng, H. Q., Li, J., Li, Y. F., Su, H. B., and Wang, X. J. (2012). Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in mice. Circ. Res. 111, 532-542.
46. Van Leeuwen, F. W., de Kleijn, D. P. V., van den Hurk, H. H., Neubauer, A., Sonnemans, M. A. F., Sluijs, J. A., et al. (1998). Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279, 242-247.
47. Visekruna, A., Joeris, T., Schmidt, N., Lawrenz, M., Ritz, J. P., Buhr, H. J., et al. (2009). Comparative expression analysis and characterization of 20S proteasomes in human intestinal tissues: the proteasome pattern as diagnostic tool for IBD patients. Inflamm. Bowel Dis. 15, 526-533.
48. Voigt, A., Jakel, S., Textoris-Taube, K., Keller, C., Drung, I., Szalay, G., et al. (2010). Generation of in silico predicted coxsackievirus B3-derived MHC class I epitopes by proteasomes. Amino Acids 39, 243-255.
49. Whitby, F. G., Masters, E. I., Kramer, L., Knowlton, J. R., Yao, Y., Wang, C. C., et al. (2000). Structural basis for the activation of 20S proteasomes by 11S regulators. Nature 408, 115-120.
50. Yu, X., and Kem, D. C. (2010). Proteasome inhibition during myocardial infarction. Cardiovasc. Res. 85, 312-320.